Buy 6-EAPB for sale online from USA vendor
Discount program: 5% OFF for the second order, 7% OFF for the third order.
Shop with us securely! We offer re-shipment guarantees.
We always provide new, legal products of impeccable quality.
Please make sure that the product is legal in your country and not under any restrictions before ordering.
We do not sell pharmaceutical products or controlled substances.
What is 6-EAPB
6-EAPB often referred to as 1-(benzofuran-6-yl)-N-ethylpropan-2-amine, is a new benzofuran-class substance that has recently acquired favour among certain recreational drug users. It has the potential to be psychedelic and entactogenic, although its effects and safety profile are poorly understood. This page will describe 6-EAPB, its chemical structure, and its relation to other compounds in its class. The present status of the study on this substance's effects on the human body and mind will also be discussed.
Introduction to 6-EAPB
In the early 2010s, 6-EAPB was recognized for the first time as a novel psychoactive compound. It is structurally linked to popular recreational compounds such as 6-APB and MDMA, and its effects are believed to be comparable to those of these narcotics. In contrast to these well-studied medications, 6-EAPB is mainly obscure, and its effects and safety profile are little understood.
Chemical Structure of 6-EAPB
6-EAPB belongs to the benzofuran drug class, a subclass of the phenethylamine chemical class. 6-EAPB has a benzofuran ring, an ethyl chain, and an amine group in its chemical structure. This structure is comparable to prominent recreational drugs such as 6-APB and MDMA, which are likewise benzofuran and phenethylamine compounds.
How 6-EAPB Compares to Other Drugs in its Class
6-EAPB is structurally similar to 6-APB and MDMA, two prominent recreational drugs. 6-APB is a stimulant and entactogen frequently abused for its euphoric effects. MDMA, on the other hand, is a well-known and often-used recreational substance with euphoric and empathogenic effects.
Potential Dangers of Using 6-EAPB
Several possible risks are associated with 6-EAPB usage, including bodily and psychological damage. There is a danger of significant injury, including overdose and death, associated with 6-EAPB's effects on the human body and mind, which are little understood.
Additionally, 6-EAPB is unregulated, and its purity is frequently unknown. Therefore, those who take 6-EAPB run the risk of ingesting a chemical containing potentially dangerous pollutants.
FAQ
Is 6-EAPB legal?
The legal status of 6-EAPB may vary by location, and it's essential to research local laws and regulations.
What effects does 6-EAPB produce?
While it's believed to have psychedelic and entactogenic potential, the specific effects of 6-EAPB are not well-understood and can vary among individuals.
What is the history of 6-EAPB?
6-EAPB was first recognized as a novel psychoactive compound in the early 2010s. It shares structural similarities with other well-known recreational drugs but lacks a comprehensive study of its effects and safety profile.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics